Ardian buyouts team takes ownership stake in ANGUS

The $100 billion private investment firm Ardian announced that it acquired a 50% ownership stake in ANGUS Chemical Company from Golden Gate Capital in a deal valued at $2.25 billion. Golden Gate’s stake that was initially acquired in February 2015 from The Dow Chemical Company, and it will retain its 50% stake in ANGUS, an Illinois-headquartered company that makes solutions that are widely used in applications to help combat the spread of COVID-19, including high-alcohol hand sanitizer gels, diagnostic kits, antibody treatments and vaccines. Officials said that over the last five years, Golden Gate has grown the business while repositioning it to focus on premium consumer applications. Ardian and Golden Gate together will partner with ANGUS President and CEO David Neuberger and the company’s current senior management team to grow the business through investment in core markets supplemented by development of application adjacencies and of new-to-world molecules. “Management and Golden Gate Capital have built an impressive Company and we are delighted to partner with them on this next phase of growth,” Thibault Basquin, head of Americas investments at Ardian Buyout stated. “ANGUS plays a critical role in the life sciences and personal care value chains, and its products have supported dozens of essential businesses over the last few months.” Basquin highlighted that Ardian has expertise and an extensive network in the sectors served by ANGUS, and intends to support the company in the implementation of a global buy and build strategy, which is similar to Ardian’s approach with other successful investments. “Ardian’s interest in ANGUS is a testament to our resilience, consistent growth, talented team and the extraordinary value of our current product portfolio and R&D pipeline,” said ANGUS’ Neuberger. “Likewise, Golden Gate Capital’s continued ownership in ANGUS is a testament to their belief in our future prospects.” Christopher Sand, director at Ardian Buyout added, “Over the last five years, ANGUS has prospered. ANGUS’ highly-regarded management team, unique product set, resilience, and growth prospects – both organic and via acquisition – makes it an ideal investment for Ardian, and we look forward to partnering with Golden Gate Capital.” With seven offices in Europe and America, Ardian’s global buyout team acquires high-quality mid and large-cap companies across Western Europe and North America, applying transformational and multi-cultural buy-and-build strategies which enable portfolio companies to become global leaders in their respective sectors. The transaction is expected to close by the end of 2020.

Continue Reading With a Free Trial

Be an Alts Watcher

Subscribe to our mailing list and know first!

Long Ridge closes oversubscribed Fund III

Fund Studio debuts with middle office tech for HFs and CTAs

Related Articles

Alts Watch Healthcare Beat: $343 million in funding from HFs, growth PE and venture debt firms

Pure play Excelsior optimistic on the opportunities in renewables

An alts-rich investment environment on the horizon

Blackstone announces logistics portfolio recapitalization

Get our daily news digest in your inbox

Get our daily news digest
in your inbox